Three things to know:
1. Dr. Kelly specializes in nonsurgical spine care and has served as director of the spine center at Atlanta-based Resurgens Orthopaedics since 2007.
2. Since 2017, he has operated as a director at CytoDyn and will continue his role as chairman of the board.
3. CytoDyn is enrolling patients in two COVID-19 clinical trials: one for people with mild-to-moderate symptoms and another for those in critical condition.
More articles on devices:
COVID-19 eases telemedicine’s shackles, expansion looks bright for orthopedics
Life Spine, Northern Light Health & more: 5 spine, orthopedic partnerships in the past month
Spinal robotics market to hit $320M by 2026: 3 updates
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.